Skip to search formSkip to main contentSkip to account menu

Danaparoid sodium

Known as: danaproid sodium 
The sodium salt form of danaparoid, a synthetic low molecular weight heparin (LMWH) derived from porcine gut mucosa with anticoagulant activity… 
National Institutes of Health

Related topics

Related topics

12 relations
Drug AllergyEnzyme Activators [MoA]Hemophilia AHemophilia B

Broader (2)

danaparoiddanaproid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides
Summary Eczematous lesions, resulting from type IV sensitizations are well-known and relatively frequent cutaneous adverse… 
2003
2003
On the Prophylactic and Therapeutic Use of Danaparoid Sodium (Orgaran®) in Patients With Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is a rare but dangerous complication of heparin prophylaxis or treatment. The present… 
Review
2002
Review
2002
Heparin-induced thrombocytopenia: Pathophysiology and new treatment options
Heparin induced thrombocytopenia (HIT) is a severe complication of heparin therapy. It is generally accompanied by a paradoxical… 
2001
2001
Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia.
2001
2001
Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2…
Recombinant adeno-associated virus type 2 (rAAV) is a promising vector for in vivo gene therapy. Transduction by rAAV requires… 
2001
2001
Danaparoid sodium (Orgaran®) in four children with heparin‐induced thrombocytopenia type II
We report on four children with heparin‐induced thrombocytopenia type II. In three patients, therapy with unfractionated heparin… 
2001
2001
Low-dose danaparoid sodium catheter flushes in an intensive care infant suffering from heparin-induced thrombocytopenia
Objective Despite controversy about whether peripheral and central venous catheters should be locked with heparin to prevent… 
Review
1999
Review
1999
Heparin-induced thrombocytopenia in paediatric patients – a review of the literature and a new case treated with danaparoid sodium
Abstract The immunological form of heparin-induced thrombocytopenia (HIT) is a potentially life-threatening adverse reaction of… 
1999
1999
Anticoagulant‐induced skin necrosis in a patient with hereditary deficiency of protein S
Skin necrosis is a rare but debilitating complication of treatment with vitamin K antagonist anticoagulants such as warfarin. A… 
Review
1998
Review
1998
Limitations of conventional treatment options for heparin-induced thrombocytopenia.
  • T. Warkentin
  • Seminars in hematology (Print)
  • 1998
  • Corpus ID: 44456009
Thrombosis is a common and potentially serious complication of immune-mediated heparin-induced thrombocytopenia (HIT… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)